|GlaxoSmithKline plc -- Mexico Stock|| |
MXN 726 19 2.69%
Ms. Victoria L. Whyte is Company Secretary of GlaxoSmithKline PLC., since 1 January 2011. She is a solicitor and a Fellow of the Institute of Chartered Secretaries and Administrators. Victoria was formerly Deputy Secretary and Secretary to the Remuneration Committee. She has acted as Secretary to the Board and all the Boards Committees since her appointment as Company Secretary on 1 January 2011.
Executive Since 2011
44 20 8047 5000 http://www.gsk.com
The company has return on total asset (ROA)
of 6.7 %
which means that it generated profit of $6.7 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 64.55 %
meaning that it generated $64.55 on every $100 dollars invested by stockholders.
The company has accumulated 25.72 B in total debt with debt to equity ratio (D/E) of 394.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. GlaxoSmithKline plc has Current Ratio of 0.63 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, overthecounter medicines, and healthrelated consumer solutions worldwide. GlaxoSmithKline plc (GSKN) is traded on Mexico Stock Exchange in Mexico. It is located in Brentford, TW GS and employs 101,255 people.